These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20424486)

  • 41. [Human chemokine receptors: structure and function].
    Waśniowska K
    Postepy Hig Med Dosw; 1999; 53(4):583-600. PubMed ID: 10544660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kidney diseases and chemokines.
    Panzer U; Steinmetz OM; Stahl RA; Wolf G
    Curr Drug Targets; 2006 Jan; 7(1):65-80. PubMed ID: 16454700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Duffy antigen facilitates movement of chemokine across the endothelium in vitro and promotes neutrophil transmigration in vitro and in vivo.
    Lee JS; Frevert CW; Wurfel MM; Peiper SC; Wong VA; Ballman KK; Ruzinski JT; Rhim JS; Martin TR; Goodman RB
    J Immunol; 2003 May; 170(10):5244-51. PubMed ID: 12734373
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemokines and chemokine receptors: biology and clinical relevance in inflammation and AIDS.
    Locati M; Murphy PM
    Annu Rev Med; 1999; 50():425-40. PubMed ID: 10073287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemokine scavenging by D6: a movable feast?
    Graham GJ; McKimmie CS
    Trends Immunol; 2006 Aug; 27(8):381-6. PubMed ID: 16814608
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemokine class differences in binding to the Duffy antigen-erythrocyte chemokine receptor.
    Szabo MC; Soo KS; Zlotnik A; Schall TJ
    J Biol Chem; 1995 Oct; 270(43):25348-51. PubMed ID: 7592697
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors.
    Nibbs RJ; Kriehuber E; Ponath PD; Parent D; Qin S; Campbell JD; Henderson A; Kerjaschki D; Maurer D; Graham GJ; Rot A
    Am J Pathol; 2001 Mar; 158(3):867-77. PubMed ID: 11238036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of the chemokine scavenger receptor D6 in balancing inflammation and immune activation.
    Borroni EM; Buracchi C; Savino B; Pasqualini F; Russo RC; Nebuloni M; Bonecchi R; Mantovani A; Locati M
    Methods Enzymol; 2009; 460():231-43. PubMed ID: 19446728
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How post-translational modifications influence the biological activity of chemokines.
    Vanheule V; Metzemaekers M; Janssens R; Struyf S; Proost P
    Cytokine; 2018 Sep; 109():29-51. PubMed ID: 29903573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A role of the Duffy antigen for the maintenance of plasma chemokine concentrations.
    Fukuma N; Akimitsu N; Hamamoto H; Kusuhara H; Sugiyama Y; Sekimizu K
    Biochem Biophys Res Commun; 2003 Mar; 303(1):137-9. PubMed ID: 12646177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6.
    Fra AM; Locati M; Otero K; Sironi M; Signorelli P; Massardi ML; Gobbi M; Vecchi A; Sozzani S; Mantovani A
    J Immunol; 2003 Mar; 170(5):2279-82. PubMed ID: 12594248
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The chemoattractant decoy receptor D6 as a negative regulator of inflammatory responses.
    Borroni EM; Buracchi C; de la Torre YM; Galliera E; Vecchi A; Bonecchi R; Mantovani A; Locati M
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1014-7. PubMed ID: 17073740
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cutting edge: the silent chemokine receptor D6 is required for generating T cell responses that mediate experimental autoimmune encephalomyelitis.
    Liu L; Graham GJ; Damodaran A; Hu T; Lira SA; Sasse M; Canasto-Chibuque C; Cook DN; Ransohoff RM
    J Immunol; 2006 Jul; 177(1):17-21. PubMed ID: 16785491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies.
    Segerer S; Nelson PJ; Schlöndorff D
    J Am Soc Nephrol; 2000 Jan; 11(1):152-176. PubMed ID: 10616852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemokine-receptor interactions: GPCRs, glycosaminoglycans and viral chemokine binding proteins.
    Lau EK; Allen S; Hsu AR; Handel TM
    Adv Protein Chem; 2004; 68():351-91. PubMed ID: 15500866
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.
    Vetrano S; Borroni EM; Sarukhan A; Savino B; Bonecchi R; Correale C; Arena V; Fantini M; Roncalli M; Malesci A; Mantovani A; Locati M; Danese S
    Gut; 2010 Feb; 59(2):197-206. PubMed ID: 19846409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cutaneous T-cell lymphoma: roles for chemokines and chemokine receptors.
    Wu XS; Lonsdorf AS; Hwang ST
    J Invest Dermatol; 2009 May; 129(5):1115-9. PubMed ID: 19242508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Role of Atypical Chemokine Receptor D6 (ACKR2) in Physiological and Pathological Conditions; Friend, Foe, or Both?
    Gowhari Shabgah A; Jadidi-Niaragh F; Mohammadi H; Ebrahimzadeh F; Oveisee M; Jahanara A; Gholizadeh Navashenaq J
    Front Immunol; 2022; 13():861931. PubMed ID: 35677043
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity.
    Whitehead GS; Wang T; DeGraff LM; Card JW; Lira SA; Graham GJ; Cook DN
    Am J Respir Crit Care Med; 2007 Feb; 175(3):243-9. PubMed ID: 17095748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy.
    Mollica Poeta V; Massara M; Capucetti A; Bonecchi R
    Front Immunol; 2019; 10():379. PubMed ID: 30894861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.